Nasdaq:US$16.36 (-0.09) | HKEX:HK$26.10 (-0.45) | AIM:£2.71 (+0.01)
新闻中心及演示文稿
上一篇文章   |   下一篇文章
演示文稿, 科学出版物 | 2010-11-30

Randomised clinical trial: herbal extract HMPL-004 in active ulcerative colitis – a double-blind comparison with sustained release mesalazine (Alimentary Pharmacology and Therapeutics 2011)